U.S. flag

An official website of the United States government

NM_002834.5(PTPN11):c.922A>G (p.Asn308Asp) AND Hereditary cancer-predisposing syndrome

Germline classification:
Pathogenic (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001293867.9

Allele description [Variation Report for NM_002834.5(PTPN11):c.922A>G (p.Asn308Asp)]

NM_002834.5(PTPN11):c.922A>G (p.Asn308Asp)

Gene:
PTPN11:protein tyrosine phosphatase non-receptor type 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.13
Genomic location:
Preferred name:
NM_002834.5(PTPN11):c.922A>G (p.Asn308Asp)
Other names:
p.N308D:AAT>GAT; NM_002834.4(PTPN11):c.922A>G
HGVS:
  • NC_000012.12:g.112477719A>G
  • NG_007459.1:g.63988A>G
  • NM_001330437.2:c.922A>G
  • NM_001374625.1:c.919A>G
  • NM_002834.5:c.922A>GMANE SELECT
  • NM_080601.3:c.922A>G
  • NP_001317366.1:p.Asn308Asp
  • NP_001361554.1:p.Asn307Asp
  • NP_002825.3:p.Asn308Asp
  • NP_002825.3:p.Asn308Asp
  • NP_542168.1:p.Asn308Asp
  • LRG_614t1:c.922A>G
  • LRG_614:g.63988A>G
  • LRG_614p1:p.Asn308Asp
  • NC_000012.11:g.112915523A>G
  • NM_001330437.1:c.922A>G
  • NM_001330437.2:c.922A>G
  • NM_002834.3:c.922A>G
  • NM_002834.4:c.922A>G
  • NM_080601.1:c.922A>G
  • Q06124:p.Asn308Asp
  • c.922A>G
  • p.(Asn308Asp)
  • p.ASN308ASP
Protein change:
N307D; ASN308ASP
Links:
UniProtKB: Q06124#VAR_015619; OMIM: 176876.0003; dbSNP: rs28933386
NCBI 1000 Genomes Browser:
rs28933386
Molecular consequence:
  • NM_001330437.2:c.922A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374625.1:c.919A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002834.5:c.922A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_080601.3:c.922A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001482282Department of Pediatric Oncology, Hematology and Clinical Immunology, University Clinics Duesseldorf
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicde novoresearch

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyes1not providednot provided1noresearch

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Department of Pediatric Oncology, Hematology and Clinical Immunology, University Clinics Duesseldorf, SCV001482282.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednoresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyes1not providednot provided1not providednot providednot provided

Last Updated: Nov 24, 2024